NGS of this third tumor biopsy revealed the tumor continued to be IDH-wild type and still harbored the FGFR3-TACC3 fusion described in the two previous biopsies (Figure 1, Supplementary Table S1). This evidence concerns the gene IDH2 and neoplasm.